BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27457810)

  • 1. A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer's mouse model via an HSF1-mediated mechanism.
    Wang B; Liu Y; Huang L; Chen J; Li JJ; Wang R; Kim E; Chen Y; Justicia C; Sakata K; Chen H; Planas A; Ostrom RS; Li W; Yang G; McDonald MP; Chen R; Heck DH; Liao FF
    Mol Psychiatry; 2017 Jul; 22(7):990-1001. PubMed ID: 27457810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the role of Hsp90 in production of heat shock proteins in motor neurons reveals a suppressive effect of wild-type Hsf1.
    Taylor DM; Tradewell ML; Minotti S; Durham HD
    Cell Stress Chaperones; 2007; 12(2):151-62. PubMed ID: 17688194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.
    Chai RC; Kouspou MM; Lang BJ; Nguyen CH; van der Kraan AG; Vieusseux JL; Lim RC; Gillespie MT; Benjamin IJ; Quinn JM; Price JT
    J Biol Chem; 2014 May; 289(19):13602-14. PubMed ID: 24692538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
    Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
    Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting HSF1 sensitizes cancer cells to HSP90 inhibition.
    Chen Y; Chen J; Loo A; Jaeger S; Bagdasarian L; Yu J; Chung F; Korn J; Ruddy D; Guo R; McLaughlin ME; Feng F; Zhu P; Stegmeier F; Pagliarini R; Porter D; Zhou W
    Oncotarget; 2013 Jun; 4(6):816-29. PubMed ID: 23615731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from yeast into whether the inhibition of heat shock transcription factor (Hsf1) by rapamycin can prevent the Hsf1 activation that results from treatment with an Hsp90 inhibitor.
    Millson SH; Piper PW
    Oncotarget; 2014 Jul; 5(13):5054-64. PubMed ID: 24970820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90 chaperone inhibitor 17-AAG attenuates Aβ-induced synaptic toxicity and memory impairment.
    Chen Y; Wang B; Liu D; Li JJ; Xue Y; Sakata K; Zhu LQ; Heldt SA; Xu H; Liao FF
    J Neurosci; 2014 Feb; 34(7):2464-70. PubMed ID: 24523537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central role of heat shock factor 1 in synaptic fidelity and memory consolidation.
    Hooper PL; Durham HD; Török Z; Hooper PL; Crul T; Vígh L
    Cell Stress Chaperones; 2016 Sep; 21(5):745-53. PubMed ID: 27283588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mixed lineage leukemia 1(MLL1) protein as a coactivator of heat shock factor 1(HSF1) protein in response to heat shock protein 90 (HSP90) inhibition.
    Chen Y; Chen J; Yu J; Yang G; Temple E; Harbinski F; Gao H; Wilson C; Pagliarini R; Zhou W
    J Biol Chem; 2014 Jul; 289(27):18914-27. PubMed ID: 24831003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In the yeast heat shock response, Hsf1-directed induction of Hsp90 facilitates the activation of the Slt2 (Mpk1) mitogen-activated protein kinase required for cell integrity.
    Truman AW; Millson SH; Nuttall JM; Mollapour M; Prodromou C; Piper PW
    Eukaryot Cell; 2007 Apr; 6(4):744-52. PubMed ID: 17293484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the Essential Function of Yeast Hsf1 Reveals a Compact Transcriptional Program for Maintaining Eukaryotic Proteostasis.
    Solís EJ; Pandey JP; Zheng X; Jin DX; Gupta PB; Airoldi EM; Pincus D; Denic V
    Mol Cell; 2016 Jul; 63(1):60-71. PubMed ID: 27320198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia.
    Ganguly S; Home T; Yacoub A; Kambhampati S; Shi H; Dandawate P; Padhye S; Saluja AK; McGuirk J; Rao R
    Oncotarget; 2015 Oct; 6(31):31767-79. PubMed ID: 26397138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
    Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
    J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1.
    Ding Y; Adachi H; Katsuno M; Sahashi K; Kondo N; Iida M; Tohnai G; Nakatsuji H; Sobue G
    Neuroscience; 2016 Jul; 327():20-31. PubMed ID: 27058144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of heat shock factor 1 maintains TAR DNA binding protein 43 solubility via induction of inducible heat shock protein 70 in cultured cells.
    Lin PY; Folorunso O; Taglialatela G; Pierce A
    J Neurosci Res; 2016 Jul; 94(7):671-82. PubMed ID: 26994698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.
    Bagatell R; Paine-Murrieta GD; Taylor CW; Pulcini EJ; Akinaga S; Benjamin IJ; Whitesell L
    Clin Cancer Res; 2000 Aug; 6(8):3312-8. PubMed ID: 10955818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain.
    Thirstrup K; Sotty F; Montezinho LC; Badolo L; Thougaard A; Kristjánsson M; Jensen T; Watson S; Nielsen SM
    Pharmacol Res; 2016 Feb; 104():197-205. PubMed ID: 26731018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation.
    Kijima T; Prince TL; Tigue ML; Yim KH; Schwartz H; Beebe K; Lee S; Budzynski MA; Williams H; Trepel JB; Sistonen L; Calderwood S; Neckers L
    Sci Rep; 2018 May; 8(1):6976. PubMed ID: 29725069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Hsf1 activity by novobiocin and geldanamycin.
    Conde R; Belak ZR; Nair M; O'Carroll RF; Ovsenek N
    Biochem Cell Biol; 2009 Dec; 87(6):845-51. PubMed ID: 19935870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSF1 deficiency and impaired HSP90-dependent protein folding are hallmarks of aneuploid human cells.
    Donnelly N; Passerini V; Dürrbaum M; Stingele S; Storchová Z
    EMBO J; 2014 Oct; 33(20):2374-87. PubMed ID: 25205676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.